T. Tanner

431 total citations
8 papers, 338 citations indexed

About

T. Tanner is a scholar working on Pharmacology, Dermatology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, T. Tanner has authored 8 papers receiving a total of 338 indexed citations (citations by other indexed papers that have themselves been cited), including 2 papers in Pharmacology, 2 papers in Dermatology and 2 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in T. Tanner's work include Advancements in Transdermal Drug Delivery (2 papers), Dermatology and Skin Diseases (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). T. Tanner is often cited by papers focused on Advancements in Transdermal Drug Delivery (2 papers), Dermatology and Skin Diseases (2 papers) and Toxin Mechanisms and Immunotoxins (1 paper). T. Tanner collaborates with scholars based in United Kingdom, France and United States. T. Tanner's co-authors include Richard A. Marks, Sue Aspley, Keith Wesnes, Shirley Williams, Garth Rapeport, Jean-Paul Dutertre, Jean‐Pierre Guichard, Philippe Pouletty, Taneli Jouhikainen and Stefano Rossi and has published in prestigious journals such as Journal of Clinical Oncology, Neuropharmacology and Skin Research and Technology.

In The Last Decade

T. Tanner

8 papers receiving 316 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
T. Tanner United Kingdom 6 152 64 52 51 41 8 338
Ivano Rondelli Italy 8 90 0.6× 75 1.2× 56 1.1× 32 0.6× 53 1.3× 13 344
Hsiu‐Ying Yu Taiwan 13 132 0.9× 38 0.6× 84 1.6× 28 0.5× 29 0.7× 37 481
Weiwei Zhu China 10 198 1.3× 84 1.3× 143 2.8× 21 0.4× 17 0.4× 13 477
C. B. Tripathi India 10 48 0.3× 46 0.7× 42 0.8× 111 2.2× 19 0.5× 32 433
Giancarlo Santus Italy 8 240 1.6× 24 0.4× 50 1.0× 30 0.6× 8 0.2× 13 430
Satyanarayana Valiveti United States 15 266 1.8× 133 2.1× 51 1.0× 263 5.2× 72 1.8× 20 602
C. Balaguer‐Fernández Spain 13 295 1.9× 101 1.6× 69 1.3× 23 0.5× 10 0.2× 23 415
A. Femenía‐Font Spain 11 237 1.6× 87 1.4× 50 1.0× 21 0.4× 6 0.1× 16 343
Syed Rizvi Oman 10 123 0.8× 21 0.3× 74 1.4× 55 1.1× 12 0.3× 27 390
Serena Tongiani Italy 12 86 0.6× 17 0.3× 104 2.0× 38 0.7× 30 0.7× 21 349

Countries citing papers authored by T. Tanner

Since Specialization
Citations

This map shows the geographic impact of T. Tanner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by T. Tanner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites T. Tanner more than expected).

Fields of papers citing papers by T. Tanner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by T. Tanner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by T. Tanner. The network helps show where T. Tanner may publish in the future.

Co-authorship network of co-authors of T. Tanner

This figure shows the co-authorship network connecting the top 25 collaborators of T. Tanner. A scholar is included among the top collaborators of T. Tanner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with T. Tanner. T. Tanner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Tanner, T., et al.. (2010). The pharmacokinetic profile of a novel fixed-dose combination tablet of ibuprofen and paracetamol. PubMed. 10(1). 10–10. 38 indexed citations
2.
Tanner, T. & Richard A. Marks. (2008). Delivering drugs by the transdermal route: review and comment. Skin Research and Technology. 14(3). 249–260. 198 indexed citations
3.
Jekunen, Antti, et al.. (2006). Dose linearity of inhaled fentanyl (FT) with comparative pharmacokinetics to transmucosal fentanyl (A). Journal of Clinical Oncology. 24(18_suppl). 8629–8629. 1 indexed citations
4.
Tanner, T.. (2000). RHUS (TOXICODENDRON) DERMATITIS. Primary Care Clinics in Office Practice. 27(2). 493–502. 16 indexed citations
5.
Rossi, Stefano, et al.. (1999). Liquid medication dispensing and dose monitoring: the Cyclotech Cyclosporine Oral Solution Dispenser. Transplantation Proceedings. 31(4). 65S–66S. 2 indexed citations
6.
Rapeport, Garth, et al.. (1996). Absence of a sertraline-mediated effect on the pharmacokinetics and pharmacodynamics of carbamazepine.. PubMed. 57 Suppl 1. 20–3. 42 indexed citations
7.
Guichard, Jean‐Pierre, et al.. (1995). A pilot study of the comparative bioavailability of estradiol from two different estradiol transdermal systems: Oesclim® 50 and Systen® 50. Current Therapeutic Research. 56(10). 1022–1032. 10 indexed citations
8.
Tanner, T.. (1979). GABA-induced locomotor activity in the rat, after bilateral injection into the ventral tegmental area. Neuropharmacology. 18(5). 441–446. 31 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026